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ABSTRACT
Analyzing gene expression patterns is a mainstay
to gain functional insights of biological systems.
A plethora of tools exist to identify significant en-
richment of pathways for a set of differentially ex-
pressed genes. Most tools analyze gene overlap be-
tween gene sets and are therefore severely hampered
by the current state of pathway annotation, yet at the
same time they run a high risk of false assignments.
A way to improve both true positive and false pos-
itive rates (FPRs) is to use a functional association
network and instead look for enrichment of network
connections between gene sets. We present a new
network crosstalk analysis method BinoX that deter-
mines the statistical significance of network link en-
richment or depletion between gene sets, using the
binomial distribution. This is a much more appro-
priate statistical model than previous methods have
employed, and as a result BinoX yields substantially
better true positive and FPRs than was possible be-
fore. A number of benchmarks were performed to
assess the accuracy of BinoX and competing meth-
ods. We demonstrate examples of how BinoX finds
many biologically meaningful pathway annotations
for gene sets from cancer and other diseases, which
are not found by other methods. BinoX is available at
http://sonnhammer.org/BinoX.
INTRODUCTION
Functional genomics techniques are routinely used to char-
acterize gene expression patterns that result from a partic-
ular biological condition. Such data can be used to deter-
mine which genes are differentially expressed between e.g.
a disease and a normal state. It is however much less triv-
ial to understand how the altered gene expression pattern
relects the altered state of the system. This requires both
knowledge of how genes are organized into functionalmod-
ules such as pathways or complexes, and a sound strategy to
project experimental data onto this knowledge. Ideally, the
method should have negligible false positive and false nega-
tive rates (i.e. high precision and recall). Designing methods
for detecting activated pathways has been the target ofmany
studies in the past (1) but is still an ongoing challenge.
Most current methods determine pathway activation by
the statistical signiicance of the overlap between the dif-
ferentially expressed genes and the genes within a pathway.
This is referred to as Gene Enrichment Analysis (GEA) and
typically uses a hypothesis test of the gene overlap based on
set theory (2). More advanced Functional Class Scoring al-
gorithms (FCS) like Gene Set Enrichment Analysis can im-
prove the results by using the gene expression level as addi-
tional information (3). Amajor drawback ofGEA and FCS
methods is the fact that our knowledge of pathways is highly
incomplete, whichmeans that the overlap with known path-
ways is often very small, often resulting in a large number
of false negatives (i.e. low coverage). Another issue is that
their statistical assumptions require the importance of all
genes to be equal and independent which is in conlict with
the organization of complex biological systems (3). Path-
way topology methods improve the situation somewhat by
using known interactions between genes within a pathway
as prior knowledge to infer whether it is activated or not (1).
This however does not increase the overlap.
Pathway analysis can be improved by using genome-
wide functional association networks, like FunCoup (4,5)
or STRING (6) as additional evidence. A simple way is to
use networks is to apply GEA to a gene set that has been
extended with adjacent networks genes. This is e.g. done
in FunCoup, STRING and (4,6–8). Network extension ap-
proachesmight increase the gene overlap but are still subject
to the same drawbacks as other gene overlap based meth-
ods. Amore sophisticated network-based approach is to an-
alyze the network crosstalk (i.e. links) between a query gene
set and a pathway, instead of the gene overlap. Here, one as-
sumes a pathway to be activated if a signiicant enrichment
of crosstalk is found (9–12).
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The fundamental assumption of network-based pathway
analysis is that the network consists of functional associa-
tions between proteins of the type that may occur within
a pathway. The accuracy of these methods depends mainly
on two factors. First, the quality of the network––if it has
low coverage or poor biological relevance it will not give
enough statistical power. Second, the suitability of the sta-
tistical model, meaning how well the method can estimate
a correct statistical model based on the network, to dis-
tinguish spurious from biologically relevant observations.
Some approaches assume a normal, Gaussian behavior of
crosstalk between gene sets (11), but it has been shown that
this only holds if the gene groups and the crosstalk within
the network fulill certain criteria (10). The online pathway
annotation method called EnrichNet estimates a distance
measure between gene sets via random walk with restart in-
stead of randomizing the whole network (12). The method
further relates the raw score to a background model based
on all pathways in the database, generating a normalized
score between 0 and ininity, yet it does not assess statistical
signiicance of the crosstalk enrichment.
Here we present BinoX, a new network-based algorithm
which substantially improves crosstalk signiicance assess-
ment with a new statistical model. Our benchmarks show
that BinoX has considerably better true positive and false
positive rates (FPRs) than competing methods such as
GEA,NEA (11) andCrossTalkZ (10). It vastly outperforms
other network-based approaches in terms of compute time.
BinoX can also work with a pre-randomized network which
further reduces the compute time and makes it suitable for
big data processing.
MATERIALS AND METHODS
Our novel network-based method BinoX was designed for
accurate high-throughput analysis of gene set crosstalk,
speciically aimed at pathway analysis. It relies on compre-
hensive functional association networks that combine sev-
eral different evidence types and represent a general view of
gene/protein interactions. The crosstalk between two gene
sets, e.g. a pathway and gene signature, is deined as the
network connection degree between them, i.e the number
of gene associations. The crosstalk is statistically signii-
cant if it is not expected from a random model of the net-
work. Because this random model is unknown we use the
principle of Monte-Carlo importance sampling (13) to ap-
proximate its parameters. By default, BinoX computes each
draw through randomizing the network based on the Link
Assignment and Second Order Conservation method (10),
which preserves the original second order topological prop-
erties and the network degree distribution within the ran-
dom model. Once the parameters of the random model are
computed, it can be used to estimate the probability of an
observed crosstalk. In some cases the randommodel can be
approximated with a normal distribution, which has been
used in other methods (10,11). The big drawback of using
a normal approximation is that one has to discard all cases
where the random model does not follow a normal distri-
bution.
Since all network connections are binary, we assume
that the crosstalk k between two gene sets follows a bino-
mial distribution .P(k) ∼ Bin(nk, pk)Here nk is the num-
ber of maximum possible connections between the gene
sets, and the probability pk denotes how likely it is to ob-
serve the measured crosstalk. The parameter pk is approx-
imated through drawing random networks and analyzing
the crosstalk within each draw. This Monte-Carlo impor-
tance sampling procedure assures the approximation of a
null hypothesis and that the results will be more accu-
rate with more random draws. If the expected crosstalk is
smaller than the observed, we calculate the P-value for the
upper tail, representing enrichment, whereas the opposite
can be seen as depletion and is determined based on the
lower tail of the distribution. Signiicant depletion can be
interpreted as evidence for the lack of functional associa-
tion between two gene sets, whereas insigniicant crosstalk
means lack of evidence for either enrichment or depletion. If
BinoX is determining the signiicance of several crosstalks
at once, it applies the Benjamini–Hochberg false discovery
rate-correction (FDR) (14) to correct for multiple hypoth-
esis testing statistics. See Figure 1 for an overview of the
BinoX algorithm.
Mathematical concepts of BinoX
Assume an undirected genome wide functional associa-
tion network with r genes. Those genes can be seen as set
V = {v1, ..., vr }. All possible connectionsV×V can be rep-
resented in a matrix X where
xi j = 1
{
i f vi connected to v j and i = j
}
, otherwi se xi j = 0
Now consider two sets of genes {A, B} ⊆ V where the
number of connections k between A and B within the net-
work X can be expressed by
k =
∑
i∈A
∑
j∈B
xi j
Since X is based on binomial relations, k following the
binomial distribution Bin(n, p), where n is the maximum
possible connections between A and B and p the probabil-
ity of observing k. The parameters p and n evolve from a
mixture of unknown binomial distributions, hence we can
not estimate them directly to approximate a proper null hy-
pothesis to compute the statistical signiicance of k. Instead
we use an alternative hypothesis H1 to test how likely it is
that one observes k by chance. For this alternative distri-
bution we evaluate N shufled networks, X′N and deine the
parameters n′ and p′ as
n′ = min
⎧⎨
⎩|A||B|,
∑
i∈A
∑
l∈V
xli ,
∑
j∈B
∑
l∈V
xl j
⎫⎬
⎭
p′ =
E(K ′)
n′
where E(K ′) =
1
N
N∑
m
k′m
By using Monte-Carlo sampling we estimate E(K ′) as an
approximation for the expected number of connections be-
tween {A, B} within a random environment X′N. Here the
law of large numbers holds so if N→∞, var (K ′)→ 0 and
E(K ′)→ K ′. We now calculate if A and B are depleted or
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Figure 1. Worklow of BinoX. The algorithm is designed to assess the
signiicance of crosstalk between multiple gene signatures and pathways
using a genome wide functional association network as evidence. During
preprocessing, BinoX validates gene set-pathway combinations by check-
ing if any crosstalk exists. A random network model is generated based
on the original network via Monte-Carlo simulation. The crosstalk sig-
niicance between each gene set-pathway combination is estimated from
the alternative (random) distribution (blue bars) and the observed original
crosstalk (red bars). Finally the program summarizes the results and ap-
plies the Benjamini–Hochberg procedure to correct for multiple testing to
distinguish between signiicant (green) and insigniicant (red) crosstalk.
enriched by testing if k has a signiicance level lower than α
by
P (reject H1, crosstalk between A and B is enriched) = P
(
k ≥ E(k′)
)
≤ α
P (reject H1, crosstalk between A and B is depleted) = P
(
k < E(k′)
)
≤ α
Stability and robustness
Since the parameter selection of the statistical model is
based on Monte-Carlo importance sampling, one can use
the concept of the law of large numbers to test for stabil-
ity and robustness. The idea is that an increased number of
random network draws, N, improves our approximation of
the unknown random network parameters, which in turn
leads to a smaller variance, var (K ′), of the estimated re-
sults. To test this we ran BinoX with different numbers of
random network draws. We used the human FunCoup 3.0
(Schmitt et al. (4)) network and estimated in each run the
crosstalk between 250 and 1000 randomly generated gene
sets. After calculating the relative change of the results we
were able to determine an uncertainty error distribution for
each setting (see Supplementary Figure S1a). If N→∞,
var (K ′)→ 0 and the Laplace shaped density functions ap-
proximates a Dirac delta function resulting in an error of
uncertainty of 0. As expected, the variance of the results de-
creases with increasing number of draws, illustrated in Sup-
plementary Figure S1b. The results based on 10, 150 and
400 random network draws produced a variance of ∼34.5,
∼10 and∼6.2% respectively. This shows that the estimation
procedure of BinoX is converging already at a relatively low
number of draws indicating that our statistical model is very
well suited for the task of describing crosstalk in a random
network.
Typical gene overlap
Benchmark datasets can have an arbitrary amount of over-
lap. However, GEA can only detect pathway enrichment if
a gene overlap exists, yet if the overlap is large it will always
detect it. To make our benchmark datasets as realistic as
possible, we therefore chose a gene overlap level that mim-
ics the gene overlap between all KEGG and MSigDB gene
sets, see Supplementary Figure S2.
True positives
To generate a representative test case scenario for evaluat-
ing the true positive rate (TPR) we used 288 human KEGG
pathways and divided them into two parts with a typical
amount of gene overlap. The overlap should simulate a real
world example and is needed to calculate enrichment with
GEA. To simulate a typical overlap we approximated a dis-
tribution representing the overlaps between all KEGG and
MSigDB gene sets. As a result 5.6% of the bisected path-
ways have an overlap of at least one gene. The median value
of all overlaps is four genes.
False positives
To test false positives we used the 288 bisectedKEGGpath-
ways and randomized them preserving their size and con-
nection degree within the network. To preserve the connec-
tion degree distribution of the original bisected pathways,
each gene was replaced by a gene having a similar degree in
the biological network. Genes present in the other half are
allowed to be drawn to obtain a typical overlap to enable
detection by GEA. In this dataset, 6.6% of the generated
gene set pairs have a gene overlap and these have a mean
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overlap of 4.6 genes (overall the mean overlap is 0.3). Af-
ter swapping the genes, the resulting random bisected path-
ways have network connection properties close to the orig-
inal but without biological meaning. Therefore a detected
enrichment between the pathway halves is considered as a
false positive.
Genome wide functional association network
The human FunCoup 3.0 (4,5) database integrates nine
different evidence types, mRNA co-expression, protein–
protein interaction, phylogenetic proile similarity, shared
transcription factor binding, subcellular co-localization,
co-miRNA regulation by sharedmiRNA targeting, domain
interactions, protein co-expression and genetic interaction
proile similarity. The FunCoup 3.0 network possesses scale
free properties, containing the highest connected node with
4069 links and the smallest with 1. To evaluate the speed we
used the human FunCoup 3.0 network at different coni-
dence score cutoffs, see Supplementary Table S1. All other
benchmarks and tests are based on the human FunCoup
v3.0 network using all links with a conidence score 0.75 (1
123 873 links, 12 391 nodes).
Data access
The 2392 MSigDB gene sets were taken from the
C2.CGP (chemical and genetic perturbations) v3.0 collec-
tion, downloaded from http://software.broadinstitute.org/
gsea/msigdb/download ile.jsp ilePath=/resources/msigdb/
3.0/c2.cgp.v3.0.symbols.gmt. The 288 human pathways
were gathered from KEGG Release 70.1 via http://www.
kegg.jp/kegg/rest/keggapi.html. Furthermore we used the
human genome wide functional association network from
FunCoup v3.0 build 2014-02 available at http://funcoup.
sbc.su.se/downloads/.
Used software
NEA http://research.scilifelab.se/andrej alexeyenko/
downloads.html, CrossTalkZ v1.3.3 http://sonnhammer.
sbc.su.se/download/software/CrossTalkZ/, BinoX v0.9.3
http://sonnhammer.org/BinoX
RESULTS
Benchmarking true positive rate
Functionally associated gene sets are likely to have signif-
icant crosstalk between them. This implies that functional
gene sets, for instance pathways, are likely to have signiicant
intra-crosstalk as well. We thus reasoned that a benchmark
of true positives may be constructed by splitting known
pathways into parts and measuring a method’s ability to re-
connect these parts.
A benchmark dataset was constructed from 288 human
pathways from KEGG (15) which were divided into two
parts with typical amounts of gene overlap (see ‘Materi-
als and Methods’ section), otherwise GEA would ind no
true positives. To make it more challenging we also created
a dataset of the 25% smallest pathways only.
A B
Figure 2. True positive rate (TPR) benchmark of BinoX, NEA,
CrossTalkZ and GEA. The test was performed using KEGG pathways
separated into two parts with typical gene overlap. A true positive is de-
ined as two parts from the same pathway having signiicant crosstalk. (A)
The right panel shows the TPR for all pathways, and the left panel for
the 25% smallest pathways. (B) Venn Diagram showing the overlap of true
positives detected at FDR ≤ 0.05 by BinoX (98.1% of all detected), NEA
(96.5% of all detected), CrossTalkZ (36.0% of all detected) andGEA (3.5%
of all detected).
The advantage of using a network becomes obvious
through a direct comparison between network-based and
non-network-based methods. For FDR ≤ 0.05, GEA re-
stores only 1.4% of the pathways correctly, while BinoX at
87.5% TPR ranks in irst place followed by NEA at 86.1%
and CrossTalkZ at 32.1%. For the 25% smallest pathways
GEA’s TPR stays at 1.5%, while BinoX increases to 92.6%,
followed by NEA at 89.7% and CrossTalkZ which drops to
4.4% (see Figure 2A). If one looks at the true positives found
by allmethods at FDR≤ 0.05, BinoX identiied all true pos-
itives found byGEAandCrossTalkZ, and onlymissed 1.9%
which were detected by NEA (Figure 2B). About 3.5%were
uniquely identiied by BinoX.
Benchmarking false positive rate
To benchmark FPR we generated two datasets, each with
288 random gene sets with properties like size and con-
nection degree distribution chosen to mimic the bisected
KEGG pathways above. This ensures that the gene sets lose
their biological relevance, implying that any statistically sig-
niicant crosstalk between gene sets is a false positive. The
procedure introduced a typical degree of gene overlap, see
Materials and Methods, which enables detection by GEA.
At FDR≤ 0.05, BinoX andCrossTalkZ assigned no false
positives at all whereas NEA detected 12.5% false positives.
The overlap-based GEA assigned 84% of the pairs shar-
ing a gene as signiicant, which led to an overall FPR of
5.7% (see Figure 3). For the more challenging task of de-
tecting enrichments correctly in the smallest 25%of the gene
sets, GEA can’t test a single pair because none of them has
an overlap. NEA’s FPR increased to 23% while BinoX still
found no false positives. As the crosstalk between the small-
est gene sets is not normally distributed, the normality test
in CrossTalkZ failed for all of them, and hence reported no
false positives.
Furthermore we combined the FPR with TPR bench-
marks in a partial Receiver Operating Characteristics curve,
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Figure 3. False positive rate benchmark of CrossTalkZ, NEA, GEA and
BinoX. We generated random gene sets, mimicking the network structure
of bisected KEGG pathways. Two random gene sets having signiicant
crosstalk are deined as a false positive. The right panel shows the FPR
for all gene sets, while the left panel is limited to the 25% smallest. As there
are no overlapping genes in the latter dataset, GEA is unable to test any
associations.
Figure 4. Partial Receiver Operating Characteristics curve, combining
TPR and FPR while excluding all insigniicant hits(FDR ≥ 0.05). Here
GEA is not visible for the smallest 25% since it detects neither FP nor TP.
excluding all insigniicant results at FDR≤ 0.05 (see Figure
4). Including all gene sets, BinoX inds 88% of the true pos-
itives before including the irst false positive. Here NEA fol-
lows with 74%, CrosstalkZ with 32% and GEA with 0.3%.
Figure 5. Compute times for CrossTalkZ, NEA and BinoX. Dashed lines:
using a gene set of 120 randomly selected genes and calculating the
crosstalk to itself for different network sizes. Solid lines: crosstalks between
2392 gene signatures and 288 KEGG pathways. Here NEA is shown with
a separate scale. We did not use BinoX’s pre-randomization mode which
would have skipped the most computationally expensive part. The net-
works are from FunCoup 3.0 with link conidence 0.75, 0.8, 0.9, 0.9, 0.95,
0.99 and 1 (see Supplementary Table S1).
For the smallest 25% of the gene sets, Binox improves its
false positive free performance to 93% while NEA drops to
50%, CrossTalkZ to 5%, while no hit was reported byGEA.
Benchmarking speed
One of the biggest challenges in network-based approaches
is limiting the compute time, to be applicable for analysis
of big data. Since the compute time of network-based al-
gorithms depends heavily on the size of the network, we
applied a range of cutoffs to the scale-free FunCoup 3.0
network to make six networks of different sizes. For testing
speed we designed two scenarios. The irst scenario repre-
sents a common gene set analysis task where we calculate
the intra-crosstalk signiicance of a gene set with 120 genes.
The second scenario tests whether the algorithms can han-
dle a large scale task of running 2392 experimental gene sets
in MSigDB (16) against KEGG, which amounts to 691 288
crosstalk assessments.
The irst scenario shows that for the smallest network,
where BinoX and CrossTalkZ only took a few seconds,
NEA ran for∼6min (see Figure 5). For the largest network,
NEA took 71 min, CrossTalkZ 15 min and BinoX only 5
min. This time can be reduced to merely 45 s by setting Bi-
noX’s option to use a pre-randomized network as statistical
baseline.
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In the second scenario, using the smallest network, Bi-
noX took about half a minute, CrossTalkZ 30 min and
NEA 46 h. For the largest network, NEA took over 110 h,
CrossTalkZ 2.2 h and BinoX 7 min, which is around 1000
times faster than NEA. Using the pre-randomized network
this shrinks down to 2.2 min.
Pathway annotation with BinoX
The primary application of BinoX is to eficiently ind as-
sociations between experimental gene sets and known path-
ways, in order to obtain functional insights for a given con-
dition. Its superior accuracy offers a high chance of arriving
at a correct pathway annotation. To exemplify how BinoX
can be usedwe performed two large-scale analyses: pathway
annotation of 2392 experimental gene sets in MSigDB and
of 288 disease gene sets. Furthermore we analyzed a single
cancer gene set. For all studies we used the FunCoup 3.0
network and generated a statistical model based on 150 net-
work draws.We compared BinoX’s results to the most com-
monly used pathway annotation algorithm, GEA, based on
gene overlap as implemented in DAVID (17) and to the
network-based CrossTalkZ approach. Due to its excessive
compute time and huge FPR we excluded the NEA algo-
rithm.
Pathway annotation of MSigDB. We evaluated crosstalk
between the 2392 experimental MSigDB gene sets (‘signa-
tures’) and KEGG pathways, in total 688 896 signature-
pathway comparisons. With FunCoup 3.0, network-based
algorithms can assess the crosstalk of 85.5% (510 423) of
these. Since GEA is based on gene overlap it can only test
11.4% (68 218) of all cases. At a signiicance cutoff of FDR
= 0.05, all three methods detected 173 645 signiicantly en-
riched and 63 480 depleted signature-pathway pairs, see Ta-
ble 1. The enrichments detected by GEA were almost fully
covered by BinoX and CrossTalkZ––only 2.3% (4 044) were
detected by GEA alone. Given that BinoX and CrossTalkZ
had zero false positives in the benchmark above at this FDR
level, while GEA had 6%, these are likely to be false pos-
itives. 9.4% (16 341) of CrossTalkZ enrichments were not
covered by BinoX, BinoX further found 13.1% (22 806) en-
richments not covered by the other methods, see Figure 6.
Full results are in Supplementalry Data 1. At FDR< 0.001
BinoX found enriched pathways for 1196 more signatures
than GEA (2058 versus 862, see Table 2).
An example of novel pathway annotations
found by BinoX is the signature WATAN-
ABE ULCERATIVE COLITIS WITH CANCER UP.
BinoX identiied 20 signiicant KEGG pathways, of which
the most signiicantly enriched was Extra Cellular Matrix
(ECM) Receptor Interaction, relecting the fact that
Ulcerative Colitis (UC) as well as other Inlammatory
Bowel Diseases show organ-speciic changes in both the
composition and organization of the ECM (18). UC is
a digestive disease, resulting in problems with digestion
leading to inlammation, which is supported in the BinoX
results by the second most signiicantly enriched pathway
Protein Digestion and Absorption. Cancer related pathways
were also signiicantly enriched. These include both general
pathways like Pathways in Cancer, and more speciic ones,
Figure 6. KEGG Pathway annotation for MSigDB. The Venn diagram
is based on all signiicant pairs between 288 KEGG pathways and 2392
MSigDB gene signatures identiied at a FDR≤ 0.05. BinoX identiied 207
600, CrossTalkZ 202 670 signiicant depletions and enrichments whereas
GEA found only 25 106 signiicant enrichments.
such as Basal Cell Carcinoma which is linked to UC via a
lack of the same plasma factor (19), and Proteoglycans in
Cancer, where proteoglycans are both tied to the intestine
mucosa and are key to different aspects of cancer biology
(20). For this signature, CrossTalkZ found no signiicant
pathways, while GEA only identiiedWNT Signaling.
A further example is the LIND-
GREN BLADDER CANCER CLUSTER 2A UP
gene set, where BinoX found the ErbB signaling pathway
at the top of 81 enriched pathways. CrossTalkZ found two
signiicant pathways, and GEA found none. ErbB signaling
is involved in several aspects of cancer biology, e.g. prolif-
eration, differentiation, cell motility and survival and is a
common target in cancer treatment (21,22). Beside several
cancer pathways, also pathways in the immune response
including T-cell receptor and NK cell-mediated cytotoxicity
were enriched. Additionally, the Hepatitis B Virus (HBV)
pathway, one of the top enriched, potentially depicts the
reactivation of HBV in Bladder cancer patients undergoing
chemotherapy (23). The MicroRNAs in Cancer pathway
was also at the top of the enriched KEGG pathways, and is
supported by recent implication of microRNA expression
in bladder cancer (24). The RAS Signaling pathway has an
established role in bladder cancer (25), while the enriched
Estrogen pathway is suspected to take part in proliferation
of urothelial cells in Bladder cancer (26). The pathway
Bacterial Invasion Of Epithelial Cells was also enriched
for this bladder cancer gene set, which may hint to the
role of Bacillus Calmette-Guerin (BCG) in triggering
the immune response in Bladder cancer. BCG has been
used as immunotherapy with similar effect sizes as seen in
traditional chemotherapy (27).
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Table 1. Enrichments and depletions found by GEA, BinoX and CrossTalkZ for different datasets at FDR ≤ 0.05
Number of (% of union) enriched / depleted pathways
Dataset GEA BinoX CrossTalkZ Union
Cancer genes 32 (21.8%)/- 147 (100%)/64 (100%) 145 (98.6%)/54 (84.4%) 147/64
Disease genes 7352 (26.9%)/- 24 431 (89.3%)/5810 (86%) 23 590 (86.3%)/6 046 (88.6%) 27 333/6822
MSigDB genes 25 106 (14.6%)/- 153 255 (88.2%)/54 340 (85.6%) 145 020 (83.5%)/57 630 (90.8%) 173 645/63 480
The union represents the amount of signiicant pathways found by all methods combined.
Table 2. KEGG pathway enrichment or depletion of MSigDB signatures at FDR ≤ 0.001
Method
Signatures with
enrichments
Mean number of enriched
pathways per signature Signatures with depletions
Mean number of depleted
pathways per signature
GEA 862 2.1 0 0
BinoX 2058 40.5 1893 12.1
CrossTalkZ 2054 46.6 1762 13.1
Pathway annotation of cancer genes. We used BinoX to
calculate the signiicance between 288KEGGpathways and
the cancer gene set published by (28). This set contains 412
genes that aremutated and causally implicated in cancer de-
velopment. BinoX identiied 147 enriched and 64 depleted
KEGG pathways, while CrossTalkZ identiied 145 and 54
respectively. GEA only identiied 32 enriched terms as sig-
niicant at FDR < 0.05 (Supplementary Table S2), all of
which were also signiicantly enriched with the network-
based methods, see Table 1. One of the pathways BinoX
identiied as having a highly signiicant crosstalk with the
cancer gene set was the Neurotrophin Signaling pathway. It
contains 120 genes and shares only 14 of these with the can-
cer gene set, resulting in an FDR of 0.07 for GEA. How-
ever, in FunCoup the two groups are connected by 888 net-
work links. BinoX estimated that by chance one would ob-
serve about 440 links, resulting in a highly signiicant FDR
of 5.8 × 10−80. It has been shown that neurotrophin acti-
vates members of the tumor necrosis factor receptor super-
family (29). Furthermore, GEA missed to identify several
other central pathways in cancer, identiied by BinoX (and
CrossTalkZ) such as the MAPK Signaling (30), at FDR =
2.4× 10−69 andRAS Signaling, at FDR= 5.2× 10−69. The
MAPK Signaling pathway regulates multiple cellular func-
tions including proliferation, growth and apoptosis, and is
one of the most dysregulated pathways in cancer (31). RAS
is a sub-pathway to MAPK. The two pathways uniquely
identiied by BinoX, Gabaergic Synapse and Lysine Degra-
dation, have both been shown to have potential implications
in cancer (32,33).
Of the signiicantly depleted pathways, the lowest FDR
(5.2 × 10−208) was obtained for Olfactory Transduction
pathwaywhich consists of 294 genes, and had 73 links to the
cancer gene set. Given the network and its properties, Bi-
noX calculated an expected number of 713 links. Since Ol-
factory Transduction pathway is part of the sensory system,
involving signal transmission to the brain, it makes sense
that the cancer gene set is not functionally associated with
it. Also other brain related pathways like Parkinson’s Dis-
ease pathway (FDR = 3.1 × 10−17) and Alzheimer Disease
pathway (FDR = 1.63 × 10−13) were depleted, which in-
dicates that these are totally independent from the cancer
gene set.
Pathway annotation of diseases. We evaluated crosstalk
between 299 diseases that have at least 20 associated genes
in the Online Mendelian Inheritance in Man and genome-
wide association study databases (34), and KEGG path-
ways. Full results are in Supplementary Data 2. Of the total
86 112 possible disease-pathway pairs, 28.2% (24 431) and
27.3% (23 593) were statistically enriched (FDR ≤ 0.05) in
BinoX and CrossTalkZ respectively, while only 9.2% were
enriched in GEA (7 952), see Table 1. The overlap between
BinoX and CrossTalkZ was 21 525.
For several diseases, BinoX was the only method able to
identify several signiicant crosstalks. One such example is
Hypothalamic disease, for which BinoX identiied 24 signif-
icant pathways. CrossTalkZ and GEA found one pathway
each. The second most signiicantly enriched pathway was
Hedgehog Signaling, shown to be affected in the Pallister-
Hall syndrome, a Hypothalamic disease (35). Additionally,
several synaptic pathways (e.g. Cholinergic, Serotonergic,
Glutamatergic and Dopaminergic) were also enriched for
this disease class.
Another example is Vision disorder, where one of the
most enriched pathways among the 34 found by Bi-
noX is Oxidative Phosphorylation which is directly im-
plicated in Leber optic atrophy (http://omim.org/entry/
535000). CrossTalkZ and GEA found only one path-
way each. Furthermore, BinoX detected Phototransduction
pathway, shown to be affected in several vision disorders,
e.g. Retinitis pigmentosa (36), and Congenital Stationary
Night Blindness (37).
DISCUSSION
We have presented a new network-based method for path-
way annotation, BinoX and have shown that it offers supe-
rior performance compared to existing methods in terms of
true positive and FPRs. Compared to other network-based
methods it further offers large speed improvements of up to
three orders of magnitude. BinoX was designed with path-
way annotation in mind but may be employed for any type
of gene set analysis as long as a comprehensive functional
association network exists for the genes.
Pathway annotation is currently mostly performed with
tools that look for gene overlap between experimental gene
sets and known pathways. A great number of tools exist that
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use variants of this technique. For instance, a recently com-
piled corpus (2), lists 68 such tools. Because it would be im-
possible to include all of these in this study, we chose the
method employed by one of the most popular pathway an-
notation tools, DAVID (17). They use the ‘EASE score’ (38)
which is a conservative adjustment of Fisher’s exact test.
As noted by the authors, the normal Fisher exact test is
very sensitive to small pathways and is likely to assign sig-
niicance to an overlap of only one gene if the pathway is
suficiently small. This problem is reduced with the EASE
score by subtracting 1 from the overlap, but as shown in
this study the FPR is still very high. In fact, a pathway that
shares two genes with a gene set reaches signiicant enrich-
ment at P < 0.05 if they contain less than 33 genes each.
A practical problem of GEA is that a given gene set which
is not signiicantly overlapping a KEGG pathway, may be
signiicant, with the same overlap, to the same pathway in
e.g. PANTHER if the latter has fewer genes. Because GEA
methods only use overlapping genes as evidence, they are
limited by the state of current pathway databases. Although
GEA could only test 6.6% of the gene set pairs in the false
positive benchmark, it assigned 84% of these as signiicant.
With such a high risk of false assignment, it is question-
able if GEA is at all suitable for pathway annotation. This
is highlighted by the pathway annotation examples where
GEA fails to ind a large number of relevant pathways. In
case of the pathway annotation ofMSigDB, 90% of all pos-
sible signature-pathway pairs do not share any genes at all,
meaning they can not be analyzed by overlap based meth-
ods like GEA.
Although CrossTalkZ uses the same association network
as BinoX, it often fails because normality in the link dis-
tribution is violated. This is witnessed in the benchmarks
and examples where BinoXwas the only method able to un-
cover important relationships between MSigDB gene sets
and KEGG pathways. NEA uses the same statistical model
as CrossTalkZ, i.e. assumes a normal distribution, but does
not check for its validity. This results in a higher TPR, but at
the expense of a huge FPR. CrossTalkZ on the other hand
has a good FPR but at the expense of a very poor TPR.
Only BinoX manages to achieve a good balance between
these performance measures.
For online pathway analysis of single gene sets, we have
set up aweb server PathwaX.sbc.su.se (39) which applies the
BinoX algorithm to KEGG pathways and FunCoup net-
works.
Network-based methods can detect both crosstalk en-
richment and depletion, whereas gene overlap based meth-
ods can only detect enrichment. In what way is signiicant
depletion of a pathway functionally relevant? In our view
there are three types of crosstalk: signiicant enrichment,
signiicant depletion and insigniicant crosstalk. Signiicant
crosstalk enrichment, as with gene overlap enrichment, in-
forms about pathway activation. Signiicant crosstalk de-
pletion means that there is strong evidence that the path-
way is not activated. It however does not necessarily mean
that the pathway was ‘actively shut down’, only that there
is statistical evidence against it being activated, which may
originate from a number of different scenarios.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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